{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:05:29Z","timestamp":1780520729068,"version":"3.54.1"},"reference-count":27,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:italic>Burkholderia mallei<\/jats:italic>is the cause of glanders and a proven biological weapon. We identified and purified the type IV pilin protein of this organism to study its potential as a subunit vaccine. We found that purified pilin was highly immunogenic. Furthermore, mice infected via sublethal aerosol challenge developed significant increases in titers of antibody against the pilin, suggesting that it is expressed in vivo. Nevertheless, we found no evidence that high-titer antipilin antisera provided passive protection against a sublethal or lethal aerosol challenge and no evidence of protection afforded by active immunization with purified pilin. These results contrast with the utility of type IV pilin subunit vaccines against other infectious diseases and highlight the need for further efforts to identify protective responses against this pathogen.<\/jats:p>","DOI":"10.1128\/iai.00150-07","type":"journal-article","created":{"date-parts":[[2007,4,3]],"date-time":"2007-04-03T00:44:08Z","timestamp":1175561048000},"page":"3027-3032","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":26,"title":["The Type IV Pilin of<i>Burkholderia mallei<\/i>Is Highly Immunogenic but Fails To Protect against Lethal Aerosol Challenge in a Murine Model"],"prefix":"10.1128","volume":"75","author":[{"given":"Paula J.","family":"Fernandes","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of Maryland School of Medicine, 20 Penn Street, Baltimore, Maryland 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Guo","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Maryland School of Medicine, 20 Penn Street, Baltimore, Maryland 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Waag","sequence":"additional","affiliation":[{"name":"Bacteriology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Donnenberg","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Maryland School of Medicine, 20 Penn Street, Baltimore, Maryland 21201"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.5.2319-2325.2002"},{"key":"e_1_3_2_3_2","first-page":"1293","year":"1992","unstructured":"Bartlett, J. G. 1992. Glanders, p. 1293-1295. In S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow (ed.), Infectious diseases. W. B. Saunders Company, Philadelphia, PA.","journal-title":"Infectious diseases"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1399-3011.1998.tb01243.x","volume":"52","year":"1998","unstructured":"Cachia, P. J., L. M. Glasier, R. R. Hodgins, W. Y. Wong, R. T. Irvin, and R. S. Hodges. 1998. The use of synthetic peptides in the design of a consensus sequence vaccine for Pseudomonas aeruginosa. J. Pept. Res.52:289-299.","journal-title":"J. Pept. Res."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro885"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2006.07.004"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.28860-0"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1135(87)90030-7"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.2.1260-1264.2005"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(89)90602-7"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.55.1.235"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.7.2119-2121.2001"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-26-1-93"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1135(92)90104-2"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1135(94)00123-E"},{"key":"e_1_3_2_16_2","first-page":"268","volume":"35","year":"1944","unstructured":"McGilvray, C. D. 1944. The transmission of glanders from horse to man. Can. J. Public Health35:268-275.","journal-title":"Can. J. Public Health"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:JNMR.0000032511.89525.64"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M508099200"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01939-05"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/08958370390205092"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107263450404"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.1985.tb07277.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.1.114-118.1991"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.74.3.1958-1961.2006"},{"key":"e_1_3_2_25_2","first-page":"209","year":"2004","unstructured":"Waag, D. M., and D. DeShazer. 2004. Glanders, new insights into an old disease, p. 209-238. In L. E. Lindler, F. J. Lebeda, and G. W. Korch (ed.), Biological weapons defense: infectious diseases and counterterrorism. Humana Press, Inc., Totowa, NJ.","journal-title":"Biological weapons defense: infectious diseases and counterterrorism"},{"key":"e_1_3_2_26_2","first-page":"213","volume":"395","year":"1998","unstructured":"Wheelis, M. 1998. First shots fired in biological warfare. Nature395:213.","journal-title":"Nature"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0025727300034876"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1996.431403.x"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.00150-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.00150-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T16:50:25Z","timestamp":1707756625000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.00150-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1128\/IAI.00150-07"],"URL":"https:\/\/doi.org\/10.1128\/iai.00150-07","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"2007-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-03-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}